title: Anaphylaxis due to progesterone hypersensitivity successfully treated with omalizumab.
authors.affiliation: Respiratory Medicine and Allergology, Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy. Electronic address: heffler.enrico@gmail.com.
authors.forename: Enrico
authors.initials: E
authors.lastname: Heffler
authors.affiliation: Respiratory Medicine and Allergology, Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy.
authors.forename: Silvia
authors.initials: S
authors.lastname: Fichera
authors.affiliation: Respiratory Medicine and Allergology, Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy.
authors.forename: Giuliana
authors.initials: G
authors.lastname: Nicolosi
authors.affiliation: Respiratory Medicine and Allergology, Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy.
authors.forename: Nunzio
authors.initials: N
authors.lastname: Crimi
mesh_terms: D000485:Allergens / Q000276:immunology*; D000707:Anaphylaxis / Q000188:drug therapy* / Q000276:immunology; D000799:Angioedema; D018926:Anti-Allergic Agents / Q000627:therapeutic use*; D002648:Child; D004342:Drug Hypersensitivity / Q000188:drug therapy* / Q000276:immunology; D005260:Female; D006801:Humans; D007073:Immunoglobulin E / Q000276:immunology; D007167:Immunotherapy / Q000379:methods*; D008598:Menstruation; D000069444:Omalizumab / Q000627:therapeutic use*; D011374:Progesterone / Q000276:immunology*; D014581:Urticaria
chemical_list: D000485:Allergens; D018926:Anti-Allergic Agents; D000069444:Omalizumab; D007073:Immunoglobulin E; D011374:Progesterone